Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 10,277,000 | 9,864,000 | 10,083,000 | 1,843,000 | 12,680,000 |
| Cost of Goods | 2,007,000 | 1,826,000 | 1,940,000 | 443,000 | 2,602,000 |
| Gross Profit | 8,270,000 | 8,038,000 | 8,143,000 | 1,400,000 | 10,078,000 |
| Operating Expenses | 5,822,000 | 5,966,000 | 5,116,000 | 6,328,000 | 7,120,000 |
| Operating Income | 2,448,000 | 2,072,000 | 3,027,000 | -4,928,000 | 2,958,000 |
| Other Income | -1,878,000 | 954,000 | -185,000 | -2,942,000 | 7,769,000 |
| Pre-tax Income | 570,000 | 3,026,000 | 2,842,000 | -7,870,000 | 10,727,000 |
| Income Tax | -347,000 | 422,000 | 359,000 | -1,982,000 | 3,047,000 |
| Net Income Continuous | 917,000 | 2,604,000 | 2,483,000 | -5,887,000 | 7,680,000 |
| Net Income Discontinuous | 560,000 | 893,000 | 881,000 | 5,314,000 | 4,000 |
| Minority Interests | 8,000 | 8,000 | 9,000 | 9,000 | 4,000 |
| Net Income | $1,469,000 | $3,489,000 | $3,355,000 | $-582,000 | $7,680,000 |
| EPS Basic Total Ops | 0.26 | 0.63 | 0.60 | -0.10 | 1.38 |
| EPS Basic Continuous Ops | 0.16 | 0.47 | 0.45 | -1.06 | 1.38 |
| EPS Basic Discontinuous Ops | 0.10 | 0.16 | 0.16 | 0.95 | 0.00 |
| EPS Diluted Total Ops | 0.26 | 0.62 | 0.60 | -0.11 | 1.36 |
| EPS Diluted Continuous Ops | 0.16 | 0.46 | 0.44 | -1.04 | 1.36 |
| EPS Diluted Discontinuous Ops | 0.10 | 0.16 | 0.16 | 0.94 | 0.00 |
| EBITDA(a) | $3,656,000 | $3,271,000 | $4,193,000 | $-3,799,000 | $4,511,000 |